Cambrooke Therapeutics, Inc. (Cambrooke), an innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announced it has been acquired by Ajinomoto Co. Inc. (Ajinomoto), a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals, through its subsidiary Ajinomoto North America, Inc. Prior to the acquisition, Cambrooke was a privately-held business led by investors Galen Partners and Seventure Partners.
from Subscribe to Preparedfoods.com's RSS Feed http://ift.tt/2zzKmoQ
via IFTTT
No comments:
Post a Comment